Irene Seipelt und Director - Info zur Person

(1 - 8 von 12

)

Company Database

www.maltesebiotech.com

Aeterna Zentaris Presents Preclinical Data for Its Anti-Cancer PI3K/ Erk by Irene Seipelt, PhD, Director, Preclinical Development at Aeterna Zentaris, at the ...

Aeterna Zentaris to Present Phase 2 Results for AEZS ADVFNfr.advfn.com › actualites › Aeterna-Zentaris-to-Prese...

fr.advfn.com

Presenter: Irene Seipelt, Ph.D., Associate Director, Discovery and Preclinical Development, Aeterna Zentaris. Poster session: "Molecular-targeted therapies ...

Aeterna Zentaris Presents Preclinical Data for Its Anti ...PR Newswire

www.prnewswire.com

— Teifel, was presented by Irene Seipelt, PhD, Director, Preclinical Development at Aeterna Zentaris, at the American Association for Cancer ...

Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel...

www.prnewswire.com

... and melanoma. Both posters were presented by Irene Seipelt, Associate Director, Discovery and Preclinical Development at Aeterna Zentaris, during the 22nd ...

AEterna Zentaris to Present Phase 2 Results for AEZS BioSpace

www.biospace.com

— ... M. Gerlach Presenter: Irene Seipelt, Ph.D., Associate Director, Discovery and Preclinical Development, Aeterna Zentaris Poster session: ...

AEZS News Aeterna Zentaris (AEZS)

investorshangout.com

... M. Gerlach, K. Jung, T. Schuster and M. Teifel, was presented yesterday by Irene Seipelt, Ph. D., Director, Preclinical Development at Aeterna ...